poisar

Stocks · News reference

VivoSim Labs Announces First Commercial Sales In China For Its NAMkind Testing Services

BenzingaJul 21, 2026, 12:08 PMBenzinga Newsdesk

, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in China, opening a

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 21, 2026, 12:08 PM
Checked
Jul 21, 2026, 12:08 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading